Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe now
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About Hardman & Co.
Case Studies
Our team
News & events
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Subscribe now
Receive our latest research as soon as it is published
Investment Research & Analysis
Detailed company analysis created for specifically for investors
Tax Enhanced Services
Product reports for investors and advisors
Bespoke Services
Services for clients with specific needs
About Hardman & Co.
We are the longest-established commissioned research provider. Read our story
Case Studies
We help a wide range of clients with different needs. Read what they say about us
Our Team
Meet the Hardman & Co team members
EVENT -
Hardman & Co November Investor Forum – Registration open now
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Utilities
list companies
Tissue Regenix
Life Sciences
CellRight: Transforming US growth prospects
By
Dr Dorothea Hill
10 Aug 2017
Burford Capital
Financials
Another record set of results
By
Dr Brian Moretta
01 Aug 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Arbuthnot Banking Group Plc
Financials
Strong, profitable, growth not shown in share price
By
Mark Thomas
27 Jul 2017
Collagen Solutions Plc
Life Sciences
Transitioning to accelerated sustainable growth
By
Dr Martin Hall
25 Jul 2017
Alliance Pharma Plc
Life Sciences
International brands driving growth
By
Dr Martin Hall
24 Jul 2017
City of London Investment Group
Financials
Good yield getting better
By
Dr Brian Moretta
20 Jul 2017
Allergy Therapeutics plc
Life Sciences
Strong sales drive market share gains
By
Dr Martin Hall
19 Jul 2017
Surface Transforms
Industrial
Initiation: Riding the carbon ceramic brake revolution
By
Mike Foster
13 Jul 2017
Oxford BioMedica
Life Sciences
Major deal to supply Novartis CAR-T programmes
By
Dr Dorothea Hill
07 Jul 2017
Evgen Pharma
Life Sciences
Making clinical progress
By
Dr Martin Hall
21 Jun 2017
Burford Capital
Financials
Positive judgement from the secondary market
By
Dr Brian Moretta
14 Jun 2017
Prev
1
...
28
29
30
31
32
...
34
Next
